Xu Yu-Ping, Yang Min
Yu-Ping Xu, Min Yang, Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi 214063, Jiangsu Province, China.
World J Gastrointest Oncol. 2016 Feb 15;8(2):165-72. doi: 10.4251/wjgo.v8.i2.165.
Pancreatic cancer (PC) is a major health problem. Conventional imaging modalities show limited accuracy for reliable assessment of the tumor. Recent researches suggest that molecular imaging techniques with tracers provide more biologically relevant information and are benefit for the diagnosis of the cancer. In addition, radiopharmaceuticals also play more important roles in treatment of the disease. This review summaries the advancement of the radiolabeled compounds in the theranostics of PC.
胰腺癌（PC）是一个重大的健康问题。传统成像方式在可靠评估肿瘤方面准确性有限。最近的研究表明，带有示踪剂的分子成像技术能提供更多生物学相关信息，有利于癌症的诊断。此外，放射性药物在该疾病的治疗中也发挥着更重要的作用。这篇综述总结了放射性标记化合物在胰腺癌诊疗中的进展。
